Perfume compositions

Patent metadata

Field	Value
Publication number	US-11364184-B2
Application number	US-201615744634-A
Country	US
Kind code	B2
Filing date	Jul 13, 2016
Priority date	Jul 17, 2015
Publication date	Jun 21, 2022
Grant date	Jun 21, 2022

Abstract

A compacted perfume composition comprising at least three Performance Markers A1, each of them at a level higher than or equal to their specific Critical Compaction Concentration (CCC), respectively, the total concentration of said Performance Markers being higher than 1% by weight of the compacted perfume composition; at least one Performance Vehicle A2, the total concentration of said Performance Vehicle being higher than 10% by weight of the compacted perfume composition; and at least one Performing Diluent B1, the total concentration of said Performing Diluents being higher than 5% by weight of the compacted perfume composition.

First claim

The invention claimed is:

1. A compacted perfume composition comprising:
a) at least three Performance Markers A1, each of them at a level higher than or equal to the concentration given in parentheses, respectively, the total concentration of said Performance Markers A1 being higher than 1% by weight of the compacted perfume composition, wherein the Performance Markers A1 are selected from the group consisting of (2-(1-propoxyethoxy)ethyl)benzene (0.25%); acetophenone (0.6%); 1-(pyrazin-2-yl)ethanone (0.1%); 2,6,10-trimethylundec-9-enal (0.25%); 2-methyldecanal (0.5%); undec-10-enal (0.7%); hexanal (0.55%); heptanal (0.15%); 3,5,5-trimethylhexanal (0.45%); (E)-undec-9-enal (0.75%); 3,8,8,11a-tetramethyldodecahydro-1H-3,5a-epoxynaphtho[2,1-c]oxepine (0.05%); 1,3,4,5,6,7-hexahydro-.beta.,1,1,5,5-pentamethyl-2H-2,4a-methanonaphthalene-8-ethanol (0.15%); 2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-ol (0.1%); (4aR,5R,7aS,9R)-Octahydro-2,2,5,8,8,9a-hexamethyl-4h-4a,9-methanoazuleno[5,6-d]-1,3-dioxole (0.05%); oct-1-en-3-ol (0.2%); 7-isopentyl-2H-benzo[b][1,4]dioxepin-3(4H)-one (0.005%); 8-(sec-butyl)-5,6,7,8-tetrahydroquinoline, (0.01%); (1R,5S,E)-1,5-dimethylbicyclo[3.2.1]octan-8-one oxime (0.03%); 6-(sec-butyl)quinoline (0.1%); 7-methyl-2H-benzo[b][1,4]dioxepin-3(4H)-one (0.2%); 3-hydroxy-4,5-dimethylfuran-2(5H)-one (0.000075%); 5-isopropyl-2-methylphenol (0.4%); 5-tert-butyl-2-methyl-5-propyl-2H-furan (0.10%); (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)hepta-1,6-dien-3-one (0.5%); 2-((3,7-dimethyloct-6-en-1-yl)oxy)acetaldehyde (0.2%); 2-(2-mercaptopropan-2-yl)-5-methylcyclohexanone (0.02%); (4S)-4,7,7-trimethyl-6-thiabicyclo[3.2.1]octane (0.3%); 2-(3-phenylpropyl)pyridine (0.015%); 2-hydroxy-3-methylcyclopent-2-enone (0.3%); p-tolyl octanoate (0.15%), 1-methoxy-4-methylbenzene (0.5%); 4-isopropylbenzonitrile (0.05%); 4-isopropylbenzaldehyde (0.2%); (E)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one (0.1%); (E)-1-(2,6,6-trimethylcyclohex-3-en-1-yl)but-2-en-1-one (0.3%); decanenitrile (0.3%); (E)-dec-2-enal (0.01%); (E)-dec-4-enal (0.1%); 9-decenal (0.05%); 2-(2-(3,3,5-trimethylcyclohexyl)acetyl)cyclopentanone (0.1%); (E)-dodec-2-enal (0.1%); (E)-4-((3aS,7aS)-hexahydro-1H-4,7-methanoinden-5(6H)-ylidene)butanal (0.15%); ethyl-3 dimethyl-2(5 or 6) pyrazine (0.03%); 8-ethyl-1-oxaspiro[4.5]decan-2-one (0.03%); methyl 2,4-dihydroxy-3,6-dimethylbenzoate (0.65%); (E)-undec-9-enenitrile (0.15%); methyl oct-2-ynoate (0.15%); 1-(3,3-dimethylcyclohex-1-en-1-yl)pent-4-en-1-one (0.2%); 2-methoxyphenol (0.05%); E-hex-2-enal (0.15%); 2-ethyl-4-hydroxy-5-methylfuran-3(2H)-one (0.1%); 2-phenylpropanal (0.25%); 2-isobutyl-3-methoxypyrazine (0.000005%); 2-isobutylquinoline (0.1%); (E)-2-methoxy-4-(prop-1-en-1-yl)phenol (0.7%); 6-isopropylquinoline (0.25%); 5-(sec-butyl)-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane (0.55%); (3E,6E)-2,4,4,7-tetramethylnona-6,8-dien-3-one oxime (0.05%); bicyclo[2.2.2]oct-5-ene-2-carboxaldehyde (0.1%); 2-methoxy-3-methylpyrazine (0.2%); 2-hydroxy-3,4-dimethyl-2-cyclopenten-1-one (0.4%); 4,4,8a-trimethyldecahydronaphthalen-4a-ol (0.025%); 2-ethyl-4-methyl-1,3-thiazole (0.07%); 8-methyl-1-oxaspiro[4.5]decan-2-one (0.15%); methyl non-2-ynoate (0.1%); 10-isopropyl-2,7-dimethyl-1-oxaspiro[4.5]deca-3,6-diene (0.3%); (E)-methyl non-2-enoate (0.45%); 1-(3-methylbenzofuran-2-yl)ethanone (0.15%); (2E,6Z)-nona-2,6-dienal (0.02%); (Z)-non-6-enal (0.045%); 2-methyl-4-propyl-1,3-oxathiane (0.1%); 2-(4-methylcyclohex-3-en-1-yl)propane-2-thiol (0.0000065%); 5-methyl-2(2-methylethyl)-cyclohexanone (0.01%); 2-cyclohexylhepta-1,6-dien-3-one (0.1%); 2-phenyl-ethanal (0.2%); (2E,5E)-5,6,7-trimethylocta-2,5-dien-4-one (0.05%); 6-(sec-butyl)quinoline (0.1%); dec-9-en-1-ol (0.4%); 4-methyl-2-(2-methylprop-1-en-1-yl)tetrahydro-2H-pyran (0.4%); 4-methylene-2-phenyltetrahydro-2H-pyran (0.10%); 2,3,3-trimethyl-2,3-dihydro-1H-inden-1-one (0.1%); 2,6,6-trimethylcyclohexa-1,3-dienecarbaldehyde (0.05%); 4-vinylcyclohex-1-enecarbaldehyde (0.15%); 1-spiro[4.5]dec-7-en-7-yl-4-penten-1-one (0.15%); 2-(p-tolyl)acetaldehyde (0.1%); (E)-3,7-dimethylocta-2,6-diene-1-thiol (0.05%); 4-methylbenzaldehyde (1%); 1-(cyclopropylmethyl)-4-methoxybenzene (0.10%); E-hex-2-enal (0.15%); (E)-tridec-2-enenitrile (0.1%); 3-phenylbutanal (0.5%); 2-ethoxy-4-methylphenol (0.15%); (3E,5Z)-undeca-1,3,5-triene (0.05%); (E)-undec-2-enal (0.1%); (E)-4-isopropyl-1-methyl-2-(prop-1-en-1-yl)benzene (0.25%); (2E,6Z)-nona-2,6-dienenitrile (0.01%); and 2-(2,4-dimethylcyclohexyl)pyridine (0.05%);
b) at least one Performance Vehicle A2, the total concentration of said Performance Vehicle A2 being higher than 10% by weight of the compacted perfume composition, wherein the Performance Vehicle A2 is selected from the group consisting of dodecanal; 2-methylundecanal; (Z)-oxacycloheptadec-10-en-2-one; 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan; (E)-1-methoxy-4-(prop-1-en-1-yl)benzene; 4-methoxybenzaldehyde; butyl butanoate; 6-methoxy-2,6-dimethyloctanal; (E)-3,7-dimethylocta-2,6-dienal; (E)-1,1-dimethoxy-3,7-dimethylocta-2,6-diene; (E)-1,1-diethoxy-3,7-dimethylocta-2,6-diene; (Z)-1,1-diethoxy-3,7-dimethylocta-2,6-diene; 3,7-dimethyloct-6-enal; 3,7-dimethyloct-6-enenitrile; 2,4,4,7-tetramethyloct-6-en-3-one; (Z)-3-methylcyclotetradec-5-enone; 2H-chromen-2-one; p-cresol; 8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carbaldehyde; 2,4,6-trimethylcyclohex-3-enecarbaldehyde; allyl 2-(cyclohexyloxy)acetate; (E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one; 6-isopropyloctahydronaphthalen-2(1H)-one; 3-methyl-2-pentylcyclopent-2-enone; 1-methoxy-4-propylbenzene; 2-methoxy-4-propylphenol; 4,7-dimethyloct-6-en-3-one; (E)-3-methyl-5-(2,2,3-trimethylcyclopent-3-en-1-yl)pent-4-en-2-ol; 3-(1-ethoxyethoxy)-3,7-dimethylocta-1,6-diene; ethyl butyrate; 2-ethyl-3-hydroxy-4H-pyran-4-one; ethyl 2,6,6-trimethylcyclohexa-1,3-diene-1-carboxylate; 3-ethoxy-4-hydroxybenzaldehyde; ethyl 2-methylbutanoate; ethyl 2-hydroxybenzoate; 3-(3-isopropylphenyl)butanal; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl propionate; 3-methyldodecanenitrile; N,2-dimethyl-N-phenylbutanamide; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl isobutyrate; Geranium essence; 2-(2-hydroxypropan-2-yl)-5-methylcyclohexanol; 3-ethoxy-1,1,5-trimethylcyclohexane; 2-hexylcyclopent-2-enone; (E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl acetate; 2-hexylcyclopentanone; (1-methyl-2-((1,2,2-trimethylbicyclo[3.1.0]hexan-3-yl)methyl)cyclopropyl)methanol; (Z)-1-(1-ethoxy ethoxy)hex-3-ene; (2E,6Z)-3,7-dimethylnona-2,6-dienenitrile; (Z)-hex-3-en-1-yl methyl carbonate; (E)-methyl 2-(((2,4-dimethylcyclohex-3-en-1-yl)methylene)amino)benzoate; 2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-ol; ethyl 2-methylpentanoate; 3-methyl-5-phenylpentanal; 2,6-dimethylhept-5-enal; 1-(p-tolyl)ethanone; (E)-1,2-dimethoxy-4-(prop-1-en-1-yl)benzene; methyl 2-hydroxybenzoate; (Z)-3-methylcyclopentadec-5-enone; 2-(2-(4-methylcyclohex-3-en-1-yl)propyl)cyclopentanone; 2-ethyl-N-methyl-N-(m-tolyl)butanamide; Patchouli essence; 5-heptyldihydrofuran-2(3H)-one; 2-cyclohexylidene-2-phenylacetonitrile; 2-cyclohexylidene-2-(o-tolyl)acetonitrile; 3-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)propanal; (3aR,6S,7aS)-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-6-yl pivalate; (E)-3,3-dimethyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol; 5-pentyldihydrofuran-2(3H)-one; 2-pentylcyclopentanone; (E)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; 4-(4-hydroxyphenyl)butan-2-one; 2,4-dimethyl-4-phenyltetrahydrofuran; (2R,8aS)-3′,6-dimethyl-3,4,4a,5,8,8a-hexahydro-1H-spiro[1,4-methanonaphthalene-2,2′-oxirane]; 3-isobutyl-1-methylcyclohexanol; methyl 2-((E)-((E)-2-benzylideneheptylidene)amino)benzoate; cyclopentadecanone and hexadecanolide; (E)-5-methylheptan-3-one oxime; (E

Assignees

• Givaudan Sa

Inventors

• Moutte Maxence

Classifications

• C11B9/00 Primary

  Essential oils; Perfumes · CPC title

• A61K2800/59

  Mixtures · CPC title

• A61Q13/00

  Formulations or additives for perfume preparations (essential oils or perfumes per se C11B9/00) · CPC title

• A61K8/11 Primary

  Encapsulated compositions · CPC title

• A61K2800/49

  Solubiliser, Solubilising system · CPC title